Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
783.18 | -48,73% | -27,69% | 693.312,15 | 0,68% | 2,63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
903.30 | -1,06% | 19,47% | 4.007.181,69 | 1,04% | 18,5% |
|
NYSE:PG
Procter & Gamble
|
167.31 | -2,85% | 6,73% | 395.653,08 | 2,4% | 6,93% |
|
NYSE:JNJ
Johnson & Johnson
|
151.27 | 0% | 0% | 372.168,87 | 3,21% | 2,71% |
|
NYSE:ABBV
AbbVie
|
164.56 | -23,05% | -12,88% | 293.875,72 | 3,73% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
120.96 | 18,89% | 41,61% | 187.733,46 | 2,01% | 15,98% |
|
SWX:NOVN
Novartis
|
93.37 | 8,15% | 21,53% | 190.512,74 | 3,53% | 4,67% |
|
NYSE:ABT
Abbott Laboratories
|
103.21 | 2,43% | 15,17% | 181.078,48 | 2,11% | 9,04% |
|
NasdaqGS:AMGN
Amgen
|
314.54 | -12,26% | -3,47% | 167.619,75 | 2,88% | 5,31% |
|
NYSE:PFE
Pfizer
|
28.53 | 8,42% | 38,65% | 162.291,22 | 5,87% | -9,31% |
|
LSE:ULVR
Unilever PLC
|
42.85 | 31,93% | 45,5% | 112.880,53 | 3,44% | 1,96% |
|
ENXTPA:SAN
Sanofi
|
89.16 | 19,33% | 38,3% | 111.472,92 | 4,22% | 8,19% |
|
LSE:GSK
GSK
|
17.75 | 7,44% | 23,26% | 72.385,16 | 3,27% | 0,79% |
|
SWX:ALC
Alcon
|
80.08 | 9,95% | 25,4% | 39.591,55 | 0,3% | 8,65% |
|
LSE:RKT
Reckitt Benckiser Group
|
45.36 | 41,37% | 58,37% | 32.339,7 | 4,19% | -1,02% |
|
XTRA:BEI
Beiersdorf
|
145.35 | -1,49% | 9,6% | 32.386,61 | 0,69% | 3,11% |
|
XTRA:BAYN
Bayer
|
28.67 | 67,53% | 83,86% | 28.077,68 | 0,38% | 1,47% |
|
CPSE:COLO B
Coloplast A/S
|
850.00 | 17,55% | 35,87% | 191.114,05 | 2,47% | 4,41% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.81 | -46,21% | -42,74% | 18.450,72 | 0% | -2,6% |
|
XTRA:FRE
Fresenius SE & Co. KGaA
|
27.75 | 27,01% | 50,46% | 15.736,85 | 0% | -4,44% |
